Gut microbial and short-chain fatty acid profiles in adults with chronic constipation before and after treatment with lubiprostone

Anaerobe

Volumn 33, Issue , 2015, Pages 33-41

  Kang, Dae Wook ^a   DiBaise, John K ^b   Ilhan, Zehra Esra ^a   Crowell, Michael D ^b   Rideout, Jai Ram ^c,d   Caporaso, J Gregory ^c   Rittmann, Bruce E ^a,e   Krajmalnik Brown, Rosa ^a,e  

^a ARIZONA STATE UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c NORTHERN ARIZONA UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Arizona State University   (United States)

Author keywords

Constipation; Gut microbiome; Lubiprostone; Pyrosequencing; Short chain fatty acids

Indexed keywords

BUTYRIC ACID; HYDROGEN; ISOBUTYRIC ACID; LUBIPROSTONE; METHANE; RNA 16S; SHORT CHAIN FATTY ACID; CHLORIDE CHANNEL STIMULATING AGENT; VOLATILE FATTY ACID;

ADULT; ARTICLE; BREATH ANALYSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONSTIPATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; FATTY ACID ANALYSIS; FECES ANALYSIS; FEMALE; GENE TARGETING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; MALE; MICROBIAL COMMUNITY; POPULATION ABUNDANCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPECIES DIVERSITY; TREATMENT RESPONSE; AGED; BIODIVERSITY; CASE CONTROL STUDY; GENE DOSAGE; GENETICS; METABOLISM; METAGENOME; MICROBIOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ARCHAEA;

ADULT; AGED; BIODIVERSITY; CASE-CONTROL STUDIES; CHLORIDE CHANNEL AGONISTS; CHRONIC DISEASE; CONSTIPATION; FATTY ACIDS, VOLATILE; FEMALE; GASTROINTESTINAL MICROBIOME; GENE DOSAGE; HUMANS; LUBIPROSTONE; MALE; METAGENOME; MIDDLE AGED; RNA, RIBOSOMAL, 16S; TREATMENT OUTCOME;

EID: 84922467857     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.01.005     Document Type: Article

References (83)

1. Suares N.C., Ford A.C. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am. J. Gastroenterol. 2011, 106:1582-1591.
2. Damon H., Dumas P., Mion F. Impact of anal incontinence and chronic constipation on quality of life. Gastroenterol. Clin. Biol. 2004, 28:16-20.
3. Singh G., Lingala V., Wang H.J., Vadhavkar S., Kahler K.H., et al. Use of health care resources and cost of care for adults with constipation. Clin. Gastroenterol. Hepatol. 2007, 5:1053-1058.
4. Lembo A., Camilleri M. Current concepts: chronic constipation. N.Engl. J. Med. 2003, 349:1360-1368.
5. Maurice C.F., Haiser H.J., Turnbaugh P.J. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013, 152:39-50.
6. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
7. Kashyap P.C., Marcobal A., Ursell L.K., Larauche M., Duboc H., et al. Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 2013, 144:967-977.
8. Sahakian A.B., Jee S.R., Pimentel M. Methane and the gastrointestinal tract. Dig. Dis. Sci. 2010, 55:2135-2143.
9. Binder H.J., Mehta P. Short-chain fatty-acids stimulate active sodium and chloride absorption invitro in the rat distal colon. Gastroenterology 1989, 96:989-996.
10. Kassam Z., Collins S.M., Moayyedi P. Peripheral mechanisms in irritable bowel syndrome. N.Engl. J. Med. 2013, 368:577-578.
11. Fukumoto S., Tatewaki M., Yamada T., Fujimiya M., Mantyh C., et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R1269-R1276.
12. Mitsui R., Ono S., Karaki S., Kuwahara A. Neural and non-neural mediation of propionate-induced contractile responses in the rat distal colon. Neurogastroenterol. Motil. 2005, 17:585-594.
13. Yajima T. Contractile effect of short-chain fatty-acid on the isolated colon of the rat. J.Physiol. Lond. 1985, 368:667-678.
14. Cherbut C., Ferrier L., Roze C., Anini Y., Blottiere H., et al. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 1998, 275:G1415-G1422.
15. Dass N.B., John A.K., Bassil A.K., Crumbley C.W., Shehee W.R., et al. The relationship between the effects of short-chain fatty acids on intestinal motility invitro and GPR43 receptor activation. Neurogastroenterol. Motil. 2007, 19:66-74.
16. Squires P.E., Rumsey R.D.E., Edwards C.A., Read N.W. Effect of short-chain fatty-acids on contractile activity and fluid-flow in rat colon invitro. Am. J. Physiol. 1992, 262:G813-G817.
17. Salonen A., de Vos W.M., Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010, 156:3205-3215.
18. Zoppi G., Cinquetti M., Luciano A., Benini A., Muner A., et al. The intestinal ecosystem in chronic functional constipation. Acta Paediatr. 1998, 87:836-841.
19. Zhu L., Liu W., Alkhouri R., Baker R.D., Bard J.E., et al. Structural changes in the gut microbiome of constipated patients. Physiol. Genomics 2014, 46:679-686.
20. Khalif I.L., Quigley E.M.M., Konovitch E.A., Maximova I.D. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig. Liver Dis. 2005, 37:838-849.
21. Attaluri A., Jackson M., Valestin J., Rao S.S.C. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am. J. Gastroenterol. 2010, 105:1407-1411.
22. Bouvier M., Meance S., Bouley C., Berta J.-L., Grimaud J.-C. Effects of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173010 on colonic transit times in healthy humans. Biosci. Microflora 2001, 20:43-48.
23. Chatterjee S., Park S., Low K., Kong Y., Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am. J. Gastroenterol. 2007, 102:837-841.
24. Pimentel M., Gunsalus R.P., Rao S.S., Zhang H. Methanogens in human health and disease. Am. J. Gastroenterol. 2012, 1:28-33.
25. Crowell M.D., Harris L.A., DiBaise J.K., Olden K.W. Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation. Curr. Opin. Invest. Drugs 2007, 8:66-70.
26. Lacy B.E., Levy L.C. Lubiprostone - a chloride channel activator. J.Clin. Gastroenterol. 2007, 41:345-351.
27. - secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. Gastroenterology 2009, 137:976-985.
28. De Lisle R.C., Mueller R., Roach E. Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype. BMC Gastroenterol. 2010, 10.
29. Barish C.F., Drossman D., Johanson J.F., Ueno R. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig. Dis. Sci. 2010, 55:1090-1097.
30. Johanson J.F., Morton D., Geenen J., Ueno R. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am. J. Gastroenterol. 2008, 103:170-177.
31. Johanson J.F., Ueno R. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Aliment. Pharmacol. Ther. 2007, 25:1351-1361.
32. McKeage K., Plosker G.L., Siddiqui M.A.A. Lubiprostone. Drugs 2006, 66:873-879.
33. Colgan S.P. Swimming through the gut: implications of fluid transport on the microbiome. Dig. Dis. Sci. 2013, 58:602-603.
34. Musch M.W., Wang Y.W., Claud E.C., Chang E.B. Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota. Dig. Dis. Sci. 2013, 58:668-677.
35. Keely S., Kelly C., Weissmueller T., Burgess A., Wagner B., et al. Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome. Gut Microbes 2012, 3:250-260.
36. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., et al. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
37. Lewis S.J., Heaton K.W. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 1997, 32:920-924.
38. Kang D.W., Park J.G., Ilhan Z.E., Wallstrom G., Labaer J., et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 2013, 8:e68322.
39. Sun Y., Wolcott R.D., Dowd S.E. Tag-encoded FLX amplicon pyrosequencing for the elucidation of microbial and functional gene diversity in any environment. High-throughput Next Generation Sequencing: Methods and Application 2011, 129-141. Humana Press Inc, Totowa, NJ. Y.M. Kwon, S.C. Ricke (Eds.).
40. Caporaso J.G., Kuczynski J., Stombaugh J., Bittinger K., Bushman F.D., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7:335-336.
41. Edgar R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010, 26:2460-2461.
42. DeSantis T.Z., Hugenholtz P., Larsen N., Rojas M., Brodie E.L., et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 2006, 72:5069-5072.
43. Wang Q., Garrity G.M., Tiedje J.M., Cole J.R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007, 73:5261-5267.
44. Caporaso J.G., Bittinger K., Bushman F.D., DeSantis T.Z., Andersen G.L., et al. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 2010, 26:266-267.
45. Price M.N., Dehal P.S., Arkin A.P. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 2009, 26:1641-1650.
46. Chao A. Nonparametric estimation of the number of classes in a population. Scand. J. Stat. 1984, 11:265-270.
47. Faith D.P. Conservation evaluation and phylogenetic diversity. Biol. Conserv. 1992, 61:1-10.
48. Shannon C.E. Amathematical theory of communication. Bell Syst. Tech. J. 1948, 27:379-423.
49. Simpson E.H. Measurement of diversity. Nature 1949, 163. 688-688.
50. Magurran A.E. Ecological Diversity and it's Measurement 1988, Princeton University Press, Princeton, NJ.
51. Lozupone C., Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 2005, 71:8228-8235.
52. Penders J., Vink C., Driessen C., London N., Thijs C., et al. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol. Lett. 2005, 243:141-147.
53. Parameswaran P., Torres C.I., Lee H.S., Krajmalnik-Brown R., Rittmann B.E. Syntrophic interactions among anode respiring bacteria (ARB) and non-ARB in a biofilm anode: electron balances. Biotechnol. Bioeng. 2009, 103:513-523.
54. Anderson M.J. Anew method for non-parametric multivariate analysis of variance. Austral. Ecol. 2001, 26:32-46.
55. Anderson M.J. Distance-based tests for homogeneity of multivariate dispersions. Biometrics 2006, 62:245-253.
56. Clarke K.R. Nonparametric multivariate analyses of changes in community structure. Aust. J. Ecol. 1993, 18:117-143.
57. Mielke P.W., Berry K.J., Johnson E.S. Multi-response permutation procedures for a priori classifications. Commun. Stat. Part a-Theory Methods 1976, 5:1409-1424.
58. McArdle B.H., Anderson M.J. Fitting multivariate models to community data: a comment on distance-based redundancy analysis. Ecology 2001, 82:290-297.
59. Drossman D.A., Chey W.D., Johanson J.F., Fass R., Scott C., et al. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies. Aliment. Pharmacol. Ther. 2009, 29:329-341.
60. Qin J.J., Li R.Q., Raes J., Arumugam M., Burgdorf K.S., et al. Ahuman gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-U70.
61. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14691-14696.
62. Hugenholtz P. Exploring prokaryotic diversity in the genomic era. Genome Biol. 2002, 3.
63. Shokralla S., Spall J.L., Gibson J.F., Hajibabaei M. Next-generation sequencing technologies for environmental DNA research. Mol. Ecol. 2012, 21:1794-1805.
64. Metzker M.L. Applications of next-generation sequencing technologies - the next generation. Nat. Rev. Genet. 2010, 11:31-46.
65. Benjamini Y., Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J.R. Stat. Soc. Ser. B Methodol. 1995, 57:289-300.
66. Pimentel M., Lin H.C., Enayati P., Van den Burg B., Lee H.R., et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G1089-G1095.
67. Soares A.C.F., Lederman H.M., Fagundes-Neto U., de Morais M.B. Breath methane associated with slow colonic transit time in children with chronic constipation. J.Clin. Gastroenterol. 2005, 39:512-515.
68. Lee K.M., Paik C.N., Chung W.C., Yang J.M., Choi M.G. Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation. Eur. J. Gastroenterol. Hepatol. 2013, 25:726-732.
69. Levitt M.D., Furne J.K., Kuskowski M., Ruddy J. Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. Clin. Gastroenterol. Hepatol. 2006, 4:123-129.
70. Bond J.H., Engel R.R., Levitt M.D. Factors influencing pulmonary methane excretion in man- indirect method of studying in-situ metabolism of methane-producing colonic bacteria. J.Exp. Med. 1971, 133:572-588.
71. Bratten J.R., Spanier J., Jones M.P. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am. J. Gastroenterol. 2008, 103:958-963.
72. Hudson M.J., Tomkins A.M., Wiggins H.S., Drasar B.S. Breath methane excretion and intestinal methanogenesis in children and adults in rural Nigeria. Scand. J. Gastroenterol. 1993, 28:993-998.
73. Kim G., Deepinder F., Morales W., Hwang L., Weitsman S., et al. Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig. Dis. Sci. 2012, 57:3213-3218.
74. Zarling E.J., Ruchim M.A. Protein origin of the volatile fatty-acids isobutyrate and isovalerate in human stool. J.Lab. Clin. Med. 1987, 109:566-570.
75. Anderson A.S. Dietary factors in the etiology and treatment of constipation during pregnancy. Br. J. Obstet. Gynaecol. 1986, 93:245-249.
76. Towers A.L., Burgio K.L., Locher J.L., Merkel I.S., Safaeian M., et al. Constipation in the elderly - influence of dietary, psychological, and physiological factors. J.Am. Geriatr. Soc. 1994, 42:701-706.
77. Roberfroid M., Gibson G.R., Hoyles L., McCartney A.L., Rastall R., et al. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 2010, 104:S1-S63.
78. Macfarlane G.T., Macfarlane S., Gibson G.R. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb. Ecol. 1998, 35:180-187.
79. Chen H.-L., Lu Y.-H., Lin J., Ko L.-Y. Effects of fructooligosaccharide on bowel function and indicators of nutritional status in constipated elderly men. Nutr. Res. 2000, 20:1725-1733.
80. Chassard C., Dapoigny M., Scott K.P., Crouzet L., Del'homme C., et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment. Pharmacol. Ther. 2012, 35:828-838.
81. Soret R., Chevalier J., De Coppet P., Poupeau G., Derkinderen P., et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 2010, 138. 1772-U1749.
82. Bajka B.H., Clarke J.M., Topping D.L., Cobiac L., Abeywardena M.Y., et al. Butyrylated starch increases large bowel butyrate levels and lowers colonic smooth muscle contractility in rats. Nutr. Res. 2010, 30:427-434.
83. Rittmann B.E., Krajmalnik-Brown R., Halden R.U. Pre-genomic, genomic and postgenomic study of microbial communities involved in bioenergy. Nat. Rev. Microbiol. 2008, 6:604-612.